Provided by Tiger Trade Technology Pte. Ltd.

Merck

114.18
-0.0200-0.02%
Post-market: 114.630.4500+0.39%19:46 EDT
Volume:36.36M
Turnover:4.15B
Market Cap:283.40B
PE:15.68
High:115.18
Open:114.25
Low:112.72
Close:114.20
52wk High:125.14
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:4.66
T/O Rate:1.46%
Dividend:3.24
Dividend Rate:2.84%
EPS(TTM):7.28
EPS(LYR):7.28
ROE:36.88%
ROA:12.04%
PB:5.39
PE(LYR):15.68

Loading ...

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Chemed (CHE) and PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Yesterday

Merck Is Maintained at Neutral by Citigroup

Dow Jones
·
Mar 21

Merck price target raised to $125 from $120 at Citi

TIPRANKS
·
Mar 20

Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Solid Biosciences (SLDB) and Merck & Company (MRK)

TIPRANKS
·
Mar 20

Merck & Co Inc : Citigroup Raises Target Price to $125 From $120

THOMSON REUTERS
·
Mar 19

Jefferies Adjusts Price Target on Merck & Co. to $132 From $130, Maintains Buy Rating

MT Newswires Live
·
Mar 19

U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

Reuters
·
Mar 19

Merck & Co Inc : Jefferies Raises Target Price to $132 From $130

THOMSON REUTERS
·
Mar 19

Merck & Co. Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Merck Animal Health wins FDA label expansion for Bravecto Quantum tick control in dogs for 12 months

Reuters
·
Mar 19

FDA Approves Bravecto® Quantum (Fluralaner for Extended-Release Injectable Suspension) From Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

THOMSON REUTERS
·
Mar 19

Merck & Co: Expanded Label for Once-Yearly Parasiticide Treatment for Dogs NOW Includes Haemaphysalis Longicornis & Amblyomma Maculatum for 12 Months

THOMSON REUTERS
·
Mar 19

Merck's Global Chief Sustainability Officer: Redefining Sustainability - From Compliance Investment to Innovation Dividends

Deep News
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Merck & Company (MRK)

TIPRANKS
·
Mar 17

Merck to present long-term efficacy of GARDASIL 9, GARDASIL at EUROGIN Congress

TIPRANKS
·
Mar 17

Merck to present long-term Gardasil 9 and Gardasil efficacy data at EUROGIN 2026

Reuters
·
Mar 17

Rose the dog might have just heralded the age of programmable medicine - and here are the stocks that benefit

Dow Jones
·
Mar 17

Merck ACC.26 Data Highlights Cardio Pulmonary Pipeline Beyond Keytruda

Simply Wall St.
·
Mar 17

US judge blocks efforts to reshape childhood vaccine policy

Reuters
·
Mar 17

Merck Highlights New Data From Cardio-Pulmonary Pipeline at Acc.26 Showcasing Commitment to Advance Innovative Research

THOMSON REUTERS
·
Mar 16